Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1

Rötig A, Sidi D, Munnich A, Rustin P. Molecular insights into Friedreich’s ataxia and antioxidant-based therapies. Trends Mol Med. 2002;8:221–4.

Pandolfo M. Iron Metabolism and Mitochondrial Abnormalities in Friedreich Ataxia. Blood Cells Mol Dis. 2002;29:536–47.

Koeppen A, Dickson A. Iron in the Hallervorden-Spatz syndrome. Pediatr Neurol. 2001;25:148–55.

Gitlin JD. Aceruloplasminemia(Review). Pediatr Res. 1998;44:271–6.

Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, Riederer P, Becker G: Brain iron pathways and their relevance to Parkinson’s disease. J Neurochem. 2008;79:225–36.

Carlson ES, Stead JDH, Neal CR, Petryk A, Georgieff MK. Perinatal iron deficiency results in altered developmental expression of genes mediating energy metabolism and neuronal morphogenesis in hippocampus. Hippocampus. 2007;17:679–91.

McGrath J, Brown A, St Clair D. Prevention and schizophrenia--the role of dietary factors. Schizophr Bull. 2011;37:272–83.

Sidrak S, Yoong T, Woolfenden S. Iron deficiency in children with global developmental delay and autism spectrum disorder. J Paediatr Child Health. 2014;50:356–61.

Chen M-H, Su T-P, Chen Y-S, Hsu J-W, Huang K-L, Chang W-H, Chen T-J, Bai Y-M: Association between psychiatric disorders and iron deficiency anemia among children and adolescents: a nationwide population-based study. BMC Psychiatry. 2013;13:161.

Fretham SJB, Carlson ES, Georgieff MK. The Role of Iron in Learning and Memory. Adv Nutr. 2011;2:112–21.

Muñoz P, Humeres A. Iron deficiency on neuronal function. Biometals. 2012;25:825–35.

Muñoz P, Humeres A, Elgueta C, Kirkwood A, Hidalgo C, Núñez MT. Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J Biol Chem. 2011;286:13382–92.

Chen Y, Khan RS, Cwanger A, Song Y, Steenstra C, Bang S, Cheah JH, Dunaief J, Shindler KS, Snyder SH, Kim SF. Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity. J Neurosci. 2013;33:3582–7.

Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE, Papadopoulos V, Snyder SH: NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron. 2006;51:431–40.

Pelizzoni I, Zacchetti D, Smith CP, Grohovaz F, Codazzi F. Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J Neurochem. 2012;120:269–78.

Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008;28:197–213.

Garrick MD. Human iron transporters. Genes Nutr. 2011;6:45–54.

Lam-Yuk-Tseung S, Gros P. Distinct Targeting and Recycling Properties of Two Isoforms of the Iron. Biochemistry. 2006;45:2294–301.

Mackenzie B, Takanaga H, Hubert N, Rolfs A, Hediger M a. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem J. 2007;403:59–69.

Epsztejn S, Kakhlon O, Glickstein H, Breuer W, Cabantchik I. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem. 1997;248:31–40.

Thomas F, Serratrice G, Béguin C, Aman ES, Pierre JL, Fontecave M, Laulhere JP: Calcein as a fluorescent probe for ferric iron. J Biol Chem. 1999;274:13375–83.

Richardson D, Hefter G, May P, Webb J, Baker E. Iron chelators of the pyridoxal isonicotinoyl hydrazone class III: Formation constants with calcium(II), magnesium(II) and zinc(II). Biol Met. 1989;2:161–7.

Breuer W, Epsztejn S, Cabantchik ZI. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem. 1995;270:24209–15.

Kakhlon O, Cabantchik ZI. Introduction-serial review: iron and cellular redox status. Free Radic Biol Med. 2002;32:565–7.

Petrat F, Rauen U, de Groot H. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology. 1999;29:1171–9.

Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron : a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochemistry. 2001;356:61–9.

Lu WY, Xiong ZG, Lei S, Orser B a, Dudek E, Browning MD, MacDonald JF: G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci. 1999;2:331–8.

Kurz T, Eaton JW, Brunk UT. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol. 2011;43:1686–97.

Dong X-P, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H: The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature. 2008;455:992–6.

Mackenzie B, Ujwal ML, Chang M-H, Romero MF, Hediger M a. Divalent metal-ion transporter DMT1 mediates both H+ −coupled Fe2+ transport and uncoupled fluxes. Pflugers Arch. 2006;451:544–58.

Kunz P a, Roberts AC, Philpot BD. Presynaptic NMDA receptor mechanisms for enhancing spontaneous neurotransmitter release. J Neurosci. 2013;33:7762–9.

Berretta N, Jones R. Tonic facilitation of glutamate release by presynaptic N-methyl-d-aspartate autoreceptors in the entorhinal cortex. Neurosci Lett. 1996;75:339–44.

Crichton RR, Dexter DT, Ward RJ. Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm. 2011;118:301–14.

Snyder AM, Connor JR. Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta. 2009;1790:606–14.

Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5:863–73.

Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219–30.

Kim S, Ponka P. Effects of Interferon- γ and Lipopolysaccharide on Macrophage Iron Metabolism Are Mediated by Nitric Oxide-induced Degradation of Iron Regulatory Protein 2. J Biol Chem. 2000;275:6220–6.

Kim S, Ponka P. Nitrogen monoxide-mediated control of ferritin synthesis: Implications for macrophage iron homeostasis. Proc Natl Acad Sci U S A. 2002;99:12214–9.

Kidane TZ, Sauble E, Linder MC. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol. 2006;291:445–55.

Theil EC, Matzapetakis M, Liu X. Ferritins : iron/oxygen biominerals in protein nanocages. J Biol Inorg Chem. 2006;11:803–10.

Arosio P, Ingrassia R, Cavadini P. Ferritins: A family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 2009;1790:589–99.

Asano T, Komatsu M, Yamaguchi-Iwai Y, Ishikawa F, Mizushima N, Iwai K. Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol Cell Biol. 2011;31:2040–52.

Guilarte TR, Chen M-K. Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects. Neurotoxicology. 2007;28:1147–52.

Vergnano AM, Rebola N, Savtchenko LP, Pinheiro PS, Casado M, Kieffer BL, Rusakov DA, Mulle C, Paoletti P: Zinc Dynamics and Action at Excitatory Synapses. Neuron. 2014;82:1101–14.

Cuajungco MP, Lees GJ. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis. 1997;4:137–69.

McCord MC, Aizenman E. The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease. Front Aging Neurosci. 2014;6(April):77.

Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460:525–42.

Smart TG, Hosie AM, Miller PS. Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist. 2004;10:432–42.

Takeda A, Nakamura M, Fujii H, Tamano H. Synaptic Zn(2+) homeostasis and its significance. Metallomics. 2013;5:417–23.

Frederickson RE, Frederickson CJ, Danscher G. In situ binding of bouton zinc reversibly disrupts performance on a spatial memory task. Behav Brain Res. 1990;38:25–33.

Paoletti P. Molecular basis of NMDA receptor functional diversity. Eur J Neurosci. 2011;33:1351–65.

Sindreu C, Bayés Á, Altafaj X, Pérez-Clausell J. Zinc transporter-1 concentrates at the postsynaptic density of hippocampal synapses. Mol Brain. 2014;7:16.

Choi E-Y, Lee S, Oh H-M, Kim Y-D, Choi E-J, Kim S-H, Kim S-W, Choi S-C, Jun C-D: Involvement of protein kinase Cdelta in iron chelator-induced IL-8 production in human intestinal epithelial cells. Life Sci. 2007;80:436–45.

Wiesinger J a, Buwen JP, Buwen CJ, Unger EL, Jones BC, Beard JL. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis. J Neurochem. 2007;100:167–79.

Murphy MP, Holmgren A, Larsson N-G, Halliwell B, Chang CJ, Kalyanaraman B, Rhee SG, Thornalley PJ, Partridge L, Gems D, Nyström T, Belousov V, Schumacker PT, Winterbourn CC. Unraveling the biological roles of reactive oxygen species. Cell Metab. 2011;13:361–6.

Bae YS, Oh H, Rhee SG, Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Mol Cells. 2011;32:491–509.

Holmström KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15:411–21.

Singh N, Halliday AC, Thomas JM, Kuznetsova OV, Baldwin R, Woon ECY, Aley PK, Antoniadou I, Sharp T, Vasudevan SR, Churchill GC. A safe lithium mimetic for bipolar disorder. Nat Commun. 2013;4:1–7.

Tian J, Kim SF, Hester L, Snyder SH. S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicity. Proc Natl Acad Sci U S A. 2008;105:10537–40.

Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH. Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci U S A. 2007;104:3456–9.

Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne C a, Kazi H, Snyder SH: High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis. 2014;67C:79–87.

Bang S, Steenstra C, Kim SF. Striatum specific protein, Rhes regulates AKT pathway. Neurosci Lett. 2012;521:142–7.

Kim S, Kim SF, Maag D, Maxwell MJ, Resnick AC, Juluri KR, Chakraborty A, Koldobskiy M a, Cha SH, Barrow R, Snowman AM, Snyder SH: Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Cell Metab. 2011;13:215–21.

Chakraborty A, Koldobskiy M a, Bello NT, Maxwell M, Potter JJ, Juluri KR, Maag D, Kim S, Huang AS, Dailey MJ, Saleh M, Snowman AM, Moran TH, Mezey E, Snyder SH. Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell. 2010;143:897–910.